Overview
Updated 14 Jul 2026
Ganesh Raghu, MD, is Professor, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington at University of Washington Medical Center, Seattle, WA. The public record shows 649 publications with 71,831 citations (h-index 112), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Sarcoidosis and Beryllium Toxicity Research, Systemic Sclerosis and Related Diseases. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 12 companies, 3 NIH-funded awards (1990–2009).
- Most recent indexed publication: 2026 · The European respiratory journal
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 330.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- Chair
international committee developing evidence-based guidelines for diagnosis and management of IPF (ATS/ERS/JRS/ALAT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗ - Chair
committee developing clinical practice guidelines on diagnosis of hypersensitivity pneumonitis (ATS/JRS/ALAT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Quality of Life in IPF - Patient and Physician Perceptions
Sponsor: University of Washington
InvestigatorCompletedNCT04148157 - Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis
Sponsor: University of Washington
InvestigatorActive, not recruitingNCT02848625 - Treatment of IPF With Laparoscopic Anti-Reflux Surgery
Sponsor: University of California, San Francisco
InvestigatorCompletedNCT01982968
Industry payments
Updated 14 Jul 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202512 payments
- United Therapeutics CorporationProgram year20254 payments
- Boehringer Ingelheim International GmbHProgram year20258 payments
NIH funding
Updated 14 Jul 2026
3 NIH research awards on record, funded 1990–2009 per NIH RePORTER. The latest:
- Treatment of IPF with Laparoscopic Anti-reflux Surgery
University of California, San Francisco
FY2015$1,986,142UM1HL119089 - Treatment of IPF with Laparoscopic Anti-reflux Surgery
University of California, San Francisco
FY2014$1,942,327UM1HL119089 - Treatment of IPF with Laparoscopic Anti-reflux Surgery
University of California, San Francisco
FY2013$1,075,825UM1HL119089
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review.
The European respiratory journal
2026 - Rebuttal to "Bronchiolocentric interstitial pneumonia is a more accurate interstitial lung disease classification than hypersensitivity pneumonitis: pro".
American journal of respiratory and critical care medicine
2026 - Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Annals of the American Thoracic Society
2025
Most-cited worksby citation count (OpenAlex)
- 01
- 02Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis4,631 citations2014
- 03
- 04
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
1959 NE Pacific Street, Health Sciences Building, Campus Box 356522, Seattle, WA 98195
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pulmccsm.uw.edu ↗
- Board certified
Internal Medicine and Critical Care Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pulmccsm.uw.edu ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- Director
Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program, UW Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗ - Co-Director
Scleroderma Clinic, UW Medicine-Montlake
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Secondary affiliationsappointments beyond the home institution
- Adjunct Professor
Department of Laboratory Medicine and Pathology, University of Washington
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗ - Scientific Advisory Board member
Pulmonary Fibrosis Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Media & interviewspress, podcasts and appearances
- ERJ Podcast (October 2017): 'Lessons from IPF clinical trials over the past 25 years'
interviewed by chief editor Marc Humbert, European Respiratory Journal
2017provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →erj.ersjournals.com ↗ - Video interview
'Idiopathic Pulmonary Fibrosis - Expert Video Interview' (CPMC, YouTube)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Video
'Gastroesophageal Reflux Disease (GERD) in ILD' with Ganesh Raghu, MD (YouTube)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/scientific-contributions/Ganesh-Raghu-38883043
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
ganeshraghuconnection.wordpress.com/meet-the-team
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ganeshraghuconnection.wordpress.com ↗ - Other
consultant360.com/podcast/pulmonology/ats/ganesh-raghu-md-whether-ipf-distinct-clinical-entity
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com ↗ - Other
pulmonaryfibrosis.org/about-us/who-we-are/medical-advisory-committees/medical-advisory-board
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmonaryfibrosis.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramaswamy Govindan, MD
University of Washington
- 1,247
- publications
- 128
- h-index
- 21
- trials
Jared Baeten, MD
University of Washington
- 702
- publications
- 91
- h-index
- 11
- trials
Connie Celum, MD, MPH
University of Washington
- 627
- publications
- 92
- h-index
- 21
- trials
Helen Chu, MD, MPH
University of Washington
- 372
- publications
- 62
- h-index
- 3
- trials